Zolbetuximab, sold under the brand name Vyloy, is a monoclonal antibody used for the treatment of gastric cancer. It is a claudin 18.2-directed cytolytic...
11 KB (828 words) - 16:47, 2 November 2024
Zokinvy Zoladex zolamine (INN) zolasartan (INN) zolazepam (INN) zolbetuximab (INN) zolbetuximab-clzb zoledronic acid (INN) Zoledronic zolenzepine (INN) zoleprodolol...
10 KB (573 words) - 05:03, 24 November 2024
review to Astellas Pharma's biologics licence application (BLA) for Zolbetuximab, a monoclonal antibody targeting Claudin 18.2 (CLDN18.2), for the treatment...
27 KB (2,460 words) - 00:25, 13 September 2024
his mentor Christoph Huber. Ganymed developed the monoclonal antibody Zolbetuximab, for use against esophageal and gastrointestinal cancer. In 2016, after...
56 KB (6,118 words) - 17:41, 13 November 2024
govitecan Serplulimab Sugemalimab Tafasitamab Talquetamab Tarlatamab Teclistamab Tislelizumab Tisotumab vedotin Toripalimab Tremelimumab Zolbetuximab...
12 KB (821 words) - 02:57, 12 October 2024
(FDA). 21 November 2024. Retrieved 23 November 2024. "Astellas' Vyloy (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer" (Press release)....
137 KB (4,115 words) - 07:44, 23 November 2024
[supplied by OMIM] Isoform 2 (Claudin 18.2) is abundant in gastric tumors. Zolbetuximab targets Claudin 18.2 to help treat gastric cancers. GRCh38: Ensembl release...
5 KB (590 words) - 13:48, 29 September 2024
class of cancer drugs called ideal monoclonal antibodies and developed zolbetuximab, which is used to treat esophageal and gastric cancer. She was chief...
42 KB (3,520 words) - 04:23, 21 August 2024
govitecan Serplulimab Sugemalimab Tafasitamab Talquetamab Tarlatamab Teclistamab Tislelizumab Tisotumab vedotin Toripalimab Tremelimumab Zolbetuximab...
12 KB (758 words) - 23:46, 14 March 2024
Margetuximab Mirvetuximab soravtansine Rituximab# Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab...
4 KB (241 words) - 13:42, 14 July 2024
Margetuximab Mirvetuximab soravtansine Rituximab# Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab...
5 KB (368 words) - 15:29, 21 August 2024
Margetuximab Mirvetuximab soravtansine Rituximab# Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab...
3 KB (129 words) - 01:04, 19 July 2023